Podcast Episodes

Back to Search
Episode 89: The Uromigos Paper of the Month - Pembrolizumab in clear cell and non-clear cell renal cancer
Episode 89: The Uromigos Paper of the Month - Pembrolizumab in clear cell and non-clear cell renal cancer

Season 1 Episode 89

David McDermott describes these back to back JCO publications. 

5 years, 7 months ago

Short Long
View Episode
Episode 88: Career Development in Academic Oncology Part 3 - Walter Stadler
Episode 88: Career Development in Academic Oncology Part 3 - Walter Stadler

Season 1 Episode 88

In these podcasts, we explore academic career development with individuals in different stages of their career. 

5 years, 8 months ago

Short Long
View Episode
Episode 87: Career Development in Academic Oncology Part 2 - Monty Pal
Episode 87: Career Development in Academic Oncology Part 2 - Monty Pal

Season 1 Episode 87

In these podcasts, we explore academic career development with individuals at different stages in their career. 

5 years, 8 months ago

Short Long
View Episode
Episode 86: Career Development in Academic Oncology Part 1 - Moshe Ornstein
Episode 86: Career Development in Academic Oncology Part 1 - Moshe Ornstein

Season 1 Episode 86

In these podcasts, we explore academic career development with individuals in different stages of their career. 

5 years, 8 months ago

Short Long
View Episode
Episode 85: The CLEAR Trial
Episode 85: The CLEAR Trial

Season 1 Episode 85

Toni Choueiri discusses the phase three results

5 years, 8 months ago

Short Long
View Episode
Episode 84: Prostate cancer highlights from ASCO #GU21 with Chris Sweeney
Episode 84: Prostate cancer highlights from ASCO #GU21 with Chris Sweeney

Season 1 Episode 84

Chris explores the prostate cancer programme. 

5 years, 8 months ago

Short Long
View Episode
Episode 83: Is cabozantinib the new standard of care in papillary renal cancer?
Episode 83: Is cabozantinib the new standard of care in papillary renal cancer?

Season 1 Episode 83

Monty Pal discusses his randomised phase 2 study in papillary renal cancer. 

5 years, 8 months ago

Short Long
View Episode
Episode 82: Which is the best VEGF/immune combination for first line metastatic renal cancer?
Episode 82: Which is the best VEGF/immune combination for first line metastatic renal cancer?

Season 1 Episode 82

Eric Jonash gives a thoughtful answer to this issue. 

5 years, 8 months ago

Short Long
View Episode
Episode 81: Noah Hahn discusses front line cisplatin-ineligible PD-L1 data from 361 and 130
Episode 81: Noah Hahn discusses front line cisplatin-ineligible PD-L1 data from 361 and 130

Season 1 Episode 81

These new data are important as it is the setting where these agents are currently recommended, but we have not seen the data in this specific subset…

5 years, 8 months ago

Short Long
View Episode
Episode 80: Results for Darolutamide in non-metastatic CRPC - the Aramis trial
Episode 80: Results for Darolutamide in non-metastatic CRPC - the Aramis trial

Season 1 Episode 80

Neil Shore presents the impressive updates for the results of this trial. 

5 years, 8 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us